TXG 10x Genomics, Inc.
Company Analysis
Latest News
🟢 TXG is trading 2.2% up today, extending multi-session gains on recent acquisition, collaboration, and analyst rating
TXG is trading at $37.96 (+2.19%), continuing a strong multi-session recovery fueled by recent positive developments: * The company announced the...
🟢 TXG is trading 3.6% up today, extending rally after Barclays price target hike
TXG is trading at $37.00 (3.6% up), extending a strong multi-day rally following a Barclays price target increase to $40 and a reaffirmed Overweight rating. •...
🔴 TXG is trading 2.1% down today as it pulls back from a two-day rally sparked by a Barclays price target hike
TXG is trading at $34.98 (-2.10%) as it eases back from a significant two-day surge that saw the stock climb over 11% earlier this week. • The recent rally...
🟢 TXG is trading 5.0% up today as Barclays raises its price target to $40
TXG is trading at $36.34 (+5.03%) after Barclays maintained its Overweight rating and raised its price target to $40.00. • The stock is seeing significant...
🔴 TXG is trading 4.5% down today as investors take profits following a Barclays price target hike
TXG is trading at $33.05 (down 4.5%) in after-hours trading as investors lock in gains following a sharp regular-session rally and an updated analyst...
🟢 TXG makes sharp 10.1% jump
TXG is trading at $35.10, up 10.1% versus the comparison close of $31.87 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 TXG is trading 5.9% up today as sentiment stabilizes following recent tech rout
TXG is trading at $33.76, up 5.9% today, as the stock rebounds from last week’s sharp pullback. • The move appears driven by stabilizing market sentiment...
🔴 TXG is trading 4.5% down today amid a broader market risk-off move
TXG is trading 4.5% down at $31.46 today, moving lower in line with a broader market risk-off sentiment. • The decline extends a recent pullback following a...
🔴 TXG extends move to 5.2% down
TXG is trading at $32.97, down 5.2% versus the comparison close of $34.76 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 10x Genomics, Inc. is trading 8.2% up today, extending its strong recent rebound
10x Genomics, Inc. is trading 8.2% up at $34.76 in pre-market, extending its strong recent rebound over the past week. • The move likely reflects...
🟢 10x Genomics, Inc. makes sharp 10.1% jump
TXG is trading at $35.38, up 10.1% versus the comparison close of $32.13 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 10x Genomics, Inc. is trading 5.5% up today as Cleveland Clinic collaboration fuels momentum
10x Genomics, Inc. is trading 5.5% up at $33.89 as the stock extends gains following the announcement of a multi-year bladder cancer research collaboration...
🟢 10x Genomics, Inc. up 2.4% on Cleveland Clinic bladder cancer research collaboration
10x Genomics, Inc. is trading at $32.52 (+2.43%) today, extending a strong rally that began on June 15, driven by the announcement of a multi-year research...
🟢 10x Genomics, Inc. is trading 2.2% up today, extending momentum from yesterday's double-digit gain
10x Genomics, Inc. is trading 2.2% up at $32.94, continuing to build on momentum from the previous session despite a lack of fresh company-specific...
🟢 10x Genomics, Inc. makes sharp 10.0% jump
TXG is trading at $31.73, up 10.0% versus the comparison close of $28.84 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 10x Genomics, Inc. is trading 3.7% up today amid a broad risk-on market rally
10x Genomics, Inc. is trading at $29.91 (+3.71%) as buyers lift the stock in a broad risk-on market. • The move is consistent with a wider equity rally, with...
🔴 10x Genomics, Inc. is trading 2.44% down today after retreating from its post-acquisition rally
10x Genomics, Inc. is trading at $28.40 (-2.44%) after retreating from a post-deal rally following its acquisition of Proteintech Genomics. • Shares are...
🔴 10x Genomics, Inc. is trading 5.82% down today after giving back gains from the Proteintech Genomics deal
10x Genomics, Inc. is trading at $28.81 (-5.82%) in pre-market as the stock pulls back from a rally driven by its recent acquisition announcement. • The...
🔴 10x Genomics, Inc. is trading 2.44% down today as it gives back gains from Proteintech Genomics deal
10x Genomics, Inc. is trading at $29.84 (down 2.44%), easing after a sharp rally triggered by its announced acquisition of Proteintech Genomics. • The...
10x Genomics Acquires Proteintech Genomics, Merging RNA and Protein Analysis
10x Genomics acquired Proteintech Genomics, a division of Proteintech Group specializing in single-cell and spatial proteomic solutions. This strategic...